Indegene Ltd (INDGN) - Total Assets
Based on the latest financial reports, Indegene Ltd (INDGN) holds total assets worth Rs46.20 Billion INR (≈ $499.67 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Indegene Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Indegene Ltd - Total Assets Trend (2020–2026)
This chart illustrates how Indegene Ltd's total assets have evolved over time, based on quarterly financial data. Check Indegene Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Indegene Ltd - Asset Composition Analysis
Current Asset Composition (March 2026)
Indegene Ltd's total assets of Rs46.20 Billion consist of 56.7% current assets and 43.3% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 8.3% |
| Accounts Receivable | Rs9.82 Billion | 21.3% |
| Inventory | Rs0.00 | 0.0% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs4.83 Billion | 10.5% |
| Goodwill | Rs11.34 Billion | 24.6% |
Asset Composition Trend (2020–2026)
This chart illustrates how Indegene Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see INDGN market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Indegene Ltd's current assets represent 56.7% of total assets in 2026, a decrease from 69.6% in 2020.
- Cash Position: Cash and equivalents constituted 8.3% of total assets in 2026, down from 29.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 34.0% of total assets, an increase from 12.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 24.6% of total assets.
Indegene Ltd Competitors by Total Assets
Key competitors of Indegene Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS
|
India | Rs36.06 Billion |
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY
|
USA | $5.84 Billion |
|
DocCheck AG
XETRA:AJ91
|
Germany | €55.68 Million |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
Indegene Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.41 | 4.48 | 2.80 |
| Quick Ratio | 2.41 | 4.48 | 2.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs15.32 Billion | Rs19.66 Billion | Rs7.80 Billion |
Indegene Ltd - Advanced Valuation Insights
This section examines the relationship between Indegene Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.97 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 38.9% |
| Total Assets | Rs46.20 Billion |
| Market Capitalization | $1.35 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Indegene Ltd's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Indegene Ltd's assets grew by 38.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Indegene Ltd (2020–2026)
The table below shows the annual total assets of Indegene Ltd from 2020 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs46.20 Billion ≈ $499.67 Million |
+38.92% |
| 2025-03-31 | Rs33.26 Billion ≈ $359.68 Million |
+30.65% |
| 2024-03-31 | Rs25.46 Billion ≈ $275.30 Million |
+15.51% |
| 2023-03-31 | Rs22.04 Billion ≈ $238.34 Million |
+62.83% |
| 2022-03-31 | Rs13.53 Billion ≈ $146.37 Million |
+127.08% |
| 2021-03-31 | Rs5.96 Billion ≈ $64.46 Million |
-0.70% |
| 2020-03-31 | Rs6.00 Billion ≈ $64.91 Million |
-- |
About Indegene Ltd
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more